Basics Candel Therapeutics, Inc. Common Stock IPO Date: July 27, 2021 Sector: Healthcare Industry: Biotech Market Cap: $304.12M Activated in VL: True Average Daily Range Avg Daily Range: $0.23 | 4.95% Avg Daily Range (30 D): $0.20 | 3.59% Avg Daily Range (90 D): $0.17 | 3.00% Institutional Daily Volume Avg Daily Volume: .7M Avg Daily Volume (30 D): .77M Avg Daily Volume (90 D): .76M Trade Size Avg Trade Size (Sh.): 149 Avg Trade Size (Sh.) (30 D): 119 Avg Trade Size (Sh.) (90 D): 129 Institutional Trades Total Inst.Trades: 106 Avg Inst. Trade: $1.43M Avg Inst. Trade (30 D): $1.04M Avg Inst. Trade (90 D): $1.59M Avg Inst. Trade Volume: .19M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.11M Avg Closing Trade (30 D): $1.04M Avg Closing Trade (90 D): $2.45M Avg Closing Volume: 307.63K     News Apr 1, 2025 @ 12:01 PM Candel Therapeutics Announces Publication of Phase... Source: N/A Mar 18, 2025 @ 12:00 PM Candel Therapeutics Appoints Renowned Pancreatic C... Source: N/A Dec 12, 2024 @ 9:51 PM Candel Therapeutics Announces $80 Million Proposed... Source: N/A Sep 4, 2024 @ 12:00 PM Milestone Pharmaceuticals Appoints Industry Vetera... Source: N/A Jul 19, 2024 @ 12:41 PM Candel Therapeutics executive sells over $63k in c... Source: Investing.Com Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.09 $.15 Diluted EPS $-.09 $.13 Revenue $ $ M $ M Gross Profit $ $ $ Net Income / Loss $ $ -4.8M $ 7.38M Operating Income / Loss $ $ -11.18M $ -8.13M Cost of Revenue $ $ $ Net Cash Flow $ $ 8.52M $ -10.49M PE Ratio